
### [MONDO:0005364](http://purl.obolibrary.org/obo/MONDO_0005364)
**Label:** Graves disease

**Subclasses:** [MONDO:0010138](http://purl.obolibrary.org/obo/MONDO_0010138) (thyrotoxicosis), 

**Corr. equiv. classes:** [OMIM:275000](http://purl.obolibrary.org/obo/OMIM_275000), 

**Class expressions from DL-Learner:**

- [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) and [HP:0200028](http://purl.obolibrary.org/obo/HP_0200028) (Pretibial myxedema) 100.00%
- [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) and [HP:0100886](http://purl.obolibrary.org/obo/HP_0100886) (Abnormality of globe location) 100.00%
- [HP:0011356](http://purl.obolibrary.org/obo/HP_0011356) (Regional abnormality of skin) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0001806](http://purl.obolibrary.org/obo/HP_0001806) (Onycholysis) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0001635](http://purl.obolibrary.org/obo/HP_0001635) (Congestive heart failure) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0001597](http://purl.obolibrary.org/obo/HP_0001597) (Abnormality of the nail) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0001438](http://purl.obolibrary.org/obo/HP_0001438) (Abnormality of abdomen morphology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0000520](http://purl.obolibrary.org/obo/HP_0000520) (Proptosis) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0000315](http://purl.obolibrary.org/obo/HP_0000315) (Abnormality of the orbital region) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 100.00%


